These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6137084)

  • 1. Clastogenic effects of transplacental exposure of mouse embryos to nitrogen mustard or cyclophosphamide.
    Meyne J; Legator MS
    Teratog Carcinog Mutagen; 1983; 3(3):281-7. PubMed ID: 6137084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplacental teratogenesis and mutagenesis in mouse fetuses treated with cyclophosphamide.
    Porter AJ; Singh SM
    Teratog Carcinog Mutagen; 1988; 8(4):191-203. PubMed ID: 2906177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplacental effect of stobadine on cyclophosphamide induced micronucleus frequency in mice.
    Chorvatovicová D; Ujházy E
    Mutagenesis; 1995 Nov; 10(6):531-4. PubMed ID: 8596473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-administration of ascorbic acid with cyclophosphamide (CPA) to pregnant mice inhibits the clastogenic activity of CPA in preimplantation murine blastocysts.
    Kola I; Vogel R; Spielmann H
    Mutagenesis; 1989 Jul; 4(4):297-301. PubMed ID: 2674608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sister-chromatid exchange analyses in rodent maternal, embryonic and extra-embryonic tissues: transplacental and direct mutagen exposures.
    Allen JW; El-Nahass E; Sanyal MK; Dunn RL; Gladen B; Dixon RL
    Mutat Res; 1981 Feb; 80(2):297-311. PubMed ID: 7207486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New approaches to mutagenicity studies in animals for carcinogenic and mutagenic agents. II. Clastogenic effects determined in transplacentally treated mouse embryos.
    Adler ID
    Teratog Carcinog Mutagen; 1983; 3(4):321-34. PubMed ID: 6195749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic toxicity of cyclophosphamide and its metabolites in vitro.
    Au W; Sokova OI; Kopnin B; Arrighi FE
    Cytogenet Cell Genet; 1980; 26(2-4):108-16. PubMed ID: 7389408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenic and teratogenic effects of cyclophosphamide on the chick embryo: chromosomal aberrations and cell proliferation in affected and unaffected tissues.
    Novotná B; Jelínek R
    Teratog Carcinog Mutagen; 1990; 10(4):341-50. PubMed ID: 1980036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal administration of cyclophosphamide induces chromosomal aberrations and inhibits cell number, histone synthesis, and DNA synthesis in preimplantation mouse embryos.
    Kola I; Folb PI; Parker MI
    Teratog Carcinog Mutagen; 1986; 6(2):115-27. PubMed ID: 2874640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological and cytogenetic studies of dominant lethality induced by mitomycin C and cyclophosphamide in female germ cells. The use of Robertsonian translocations as a 'marker system' to identify the zygote pronuclei.
    Jacquet P; Pire P
    Mutat Res; 1984 Sep; 128(2):181-94. PubMed ID: 6433189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo cytogenetic effects of oil shale retort process waters.
    Meyne J; Deaven LL
    Toxicology; 1982; 24(3-4):223-9. PubMed ID: 6927642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the mode of administration of nitrogen mustard and cytosine arabinoside on the production of chromosomal aberrations in mouse bone marrow and ascites tumour cells.
    Wobus AM; Schöneich J; Thieme R
    Mutat Res; 1978 Sep; 58(1):67-77. PubMed ID: 714078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of cytogenetic damage by 2-mercaptoethanesulfonate in cultured human lymphocytes exposed to cyclophosphamide and its reactive metabolites.
    Wilmer JL; Erexson GL; Kligerman AD
    Cancer Res; 1986 Jan; 46(1):203-10. PubMed ID: 3079586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplacental genetic and cytogenetic effects of alkylating agents in the mouse. II. Induction of chromosomal aberrations.
    Braun R; Hüttner E; Schöneich J
    Teratog Carcinog Mutagen; 1986; 6(1):69-80. PubMed ID: 2874638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of food carotenoid dyes E160a and E160e on clastogenic activity of cyclophosphamide and dioxidine in mice].
    Durnev AD; Tiurina LS; Oreshchenko AV; Guseva NV; Seredenin SB
    Vestn Ross Akad Med Nauk; 1997; (7):36-9. PubMed ID: 9324380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous micronucleus and chromosome aberration assessment in the rat.
    Krishna G; Kropko ML; Ciaravino V; Theiss JC
    Mutat Res; 1991 Sep; 264(1):29-35. PubMed ID: 1881414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of mutagenic and embryotoxic effects of cyclophosphamide on the chick embryo.
    Novotná B; Jelínek R
    Environ Mutagen; 1986; 8(2):241-52. PubMed ID: 3698944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks.
    Anderson D; Bishop JB; Garner RC; Ostrosky-Wegman P; Selby PB
    Mutat Res; 1995 Aug; 330(1-2):115-81. PubMed ID: 7623863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticlastogenic activity of apo-carotene in vivo].
    Durnev AD; Tiurina LS; Guseva NV; Oreshchenko AV; Seredinin SB
    Eksp Klin Farmakol; 1997; 60(3):68-70. PubMed ID: 9324406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of indole-3-carbinol on cyclophosphamide-induced clastogenecity in mouse bone marrow cells.
    Shukla Y; Srivastava B; Arora A; Chauhan LK
    Hum Exp Toxicol; 2004 May; 23(5):245-50. PubMed ID: 15222402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.